India Contraceptive Devices Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

India's contraceptive market is a significant component of the broader Asia Pacific reproductive health sector. In 2025, the market for contraceptive drugs and devices combined is valued at approximately $1.8 billion, with projections pointing to continued expansion through 2030. The devices segment, covering intrauterine devices (IUDs), contraceptive implants, diaphragms, and barriers, operates alongside a larger drugs segment that includes oral contraceptives and injectables.

• •The overall India contraceptive drugs and devices market is valued at roughly $1.8 billion in 2025, building from prior-year revenues near $1.69 billion.
• •The contraceptive devices segment alone is estimated at approximately $264 million in 2025, with growth expected through the decade.
• •The broader Asia Pacific contraceptive devices market is valued at over $11 billion in 2025, positioning India as a key contributor to the region.

Government-led family planning initiatives remain the single largest catalyst for market expansion, with India's public health system distributing contraceptives through an extensive network of primary health centers. Concurrently, rising female literacy, workforce participation, and urbanization are driving demand for a wider range of contraceptive choices beyond traditional methods. The growing preference for long-acting reversible contraceptives (LARCs), particularly IUDs and implants, is accelerating device adoption.

• •India's national family planning programs, including free contraceptive distribution, continue to underpin volume demand across both rural and urban populations.
• •Rising awareness of reproductive health and family planning among women, supported by government and NGO outreach, is expanding the addressable market.
• •The shift toward long-acting reversible contraceptives, such as hormonal IUDs and subdermal implants, is a key growth catalyst within the devices segment.

The India contraceptive market is broadly segmented into drugs, oral pills, injectables, and patches, and devices, including IUDs, implants, and barrier methods. Devices are further categorized into hormonal and non-hormonal offerings, with IUDs commanding the largest share within the devices sub-segment due to their cost-effectiveness and long duration of action. Geographically, southern and western states such as Tamil Nadu, Kerala, and Maharashtra lead in adoption rates, reflecting higher literacy and health infrastructure, while northern and eastern states present emerging growth opportunities.

• •Intrauterine contraceptive devices are the dominant sub-segment within devices, with the Asia Pacific IUD market projected to grow substantially through 2033.
• •Hormonal devices, including hormonal IUDs and implants, are gaining share over non-hormonal alternatives as consumer preferences evolve.
• •Regional disparities persist: urban centers and high-literacy states show stronger private-sector penetration, while rural areas rely more heavily on public distribution channels.

What are the recent trends and outlook?

The market is expected to sustain its growth trajectory through 2030, driven by continued government investment in reproductive health infrastructure and expanding private-sector participation. Digital health platforms and telemedicine are emerging as new channels for contraceptive awareness and counseling, particularly in underserved regions. Regulatory support for locally manufactured devices, combined with price-sensitive public tenders, is expected to favor domestic producers while encouraging technology transfer partnerships.

• •The India contraceptive drugs and devices market is projected to grow from approximately $1.8 billion in 2025 to over $2.4 billion by 2030.
• •Long-acting reversible contraceptives, including IUDs and implants, are expected to outpace traditional short-acting methods in growth rate.
• •Government initiatives such as the National Family Planning Program and increased budgetary allocations continue to create a supportive policy environment for market expansion.